Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric C M van Gorp

Showing results (51-60 of 129) with videos related to

Pageof 13
Sort By:
Clinical Drug Investigation|May 31, 2007
Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected IndividualsMonique M R de Maat, Alwin D R Huitema, Jan W Mulder, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|September 23, 2015
Emerging Viruses in the Republic of Suriname: Retrospective and Prospective Study into Chikungunya Circulation and Suspicion of Human Hantavirus Infections, 2008-2012 and 2014Marco Goeijenbier, Georgina Aron, Fatih Anfasa, et al.
Research and Practice in Thrombosis and Haemostasis|March 18, 2021
Caging the dragon: Research approach to COVID-19-related thrombosisMarieke J H A Kruip, Suzanne C Cannegieter, Hugo Ten Cate, et al.
British Journal of Clinical Pharmacology|August 27, 2005
Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patientsBregt S Kappelhoff, Alwin D R Huitema, Sanjay U C Sankatsing, et al.
Journal of Clinical Medicine|October 14, 2023
A Transcriptomic Severity Classifier IMX-SEV-3b to Predict Mortality in Intensive Care Unit Patients with COVID-19: A Prospective Observational Pilot StudyKatrijn Daenen, Kirby Tong-Minh, Oliver Liesenfeld, et al.
AIDS (London, England)|December 20, 2007
Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcriptionServi J C Stevens, Paul H M Smits, Sandra A W M Verkuijlen, et al.
BMC Public Health|July 4, 2024
Determinants of intended prevention behaviour against mosquitoes and mosquito-borne viruses in the Netherlands and Spain using the MosquitoWise survey: cross-sectional studyPauline A de Best, Ayat Abourashed, Laura Doornekamp, et al.
Scientific Reports|January 20, 2024
Development and validation of the MosquitoWise survey to assess perceptions towards mosquitoes and mosquito-borne viruses in EuropeAyat Abourashed, Pauline A de Best, Laura Doornekamp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic feverEric C M van Gorp, Catharina Suharti, Albert T A Mairuhu, et al.
Critical Care Medicine|January 20, 2010
Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency departmentMartijn D de Kruif, Maarten Limper, Herman Gerritsen, et al.
Pageof 13

Showing results (51-60 of 129) with videos related to

Sort By:
Pageof 13
Clinical Drug Investigation|May 31, 2007
Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected IndividualsMonique M R de Maat, Alwin D R Huitema, Jan W Mulder, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|September 23, 2015
Emerging Viruses in the Republic of Suriname: Retrospective and Prospective Study into Chikungunya Circulation and Suspicion of Human Hantavirus Infections, 2008-2012 and 2014Marco Goeijenbier, Georgina Aron, Fatih Anfasa, et al.
Research and Practice in Thrombosis and Haemostasis|March 18, 2021
Caging the dragon: Research approach to COVID-19-related thrombosisMarieke J H A Kruip, Suzanne C Cannegieter, Hugo Ten Cate, et al.
British Journal of Clinical Pharmacology|August 27, 2005
Population pharmacokinetics of indinavir alone and in combination with ritonavir in HIV-1-infected patientsBregt S Kappelhoff, Alwin D R Huitema, Sanjay U C Sankatsing, et al.
Journal of Clinical Medicine|October 14, 2023
A Transcriptomic Severity Classifier IMX-SEV-3b to Predict Mortality in Intensive Care Unit Patients with COVID-19: A Prospective Observational Pilot StudyKatrijn Daenen, Kirby Tong-Minh, Oliver Liesenfeld, et al.
AIDS (London, England)|December 20, 2007
Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcriptionServi J C Stevens, Paul H M Smits, Sandra A W M Verkuijlen, et al.
BMC Public Health|July 4, 2024
Determinants of intended prevention behaviour against mosquitoes and mosquito-borne viruses in the Netherlands and Spain using the MosquitoWise survey: cross-sectional studyPauline A de Best, Ayat Abourashed, Laura Doornekamp, et al.
Scientific Reports|January 20, 2024
Development and validation of the MosquitoWise survey to assess perceptions towards mosquitoes and mosquito-borne viruses in EuropeAyat Abourashed, Pauline A de Best, Laura Doornekamp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
Changes in the plasma lipid profile as a potential predictor of clinical outcome in dengue hemorrhagic feverEric C M van Gorp, Catharina Suharti, Albert T A Mairuhu, et al.
Critical Care Medicine|January 20, 2010
Additional value of procalcitonin for diagnosis of infection in patients with fever at the emergency departmentMartijn D de Kruif, Maarten Limper, Herman Gerritsen, et al.
Pageof 13